II
TNDM icon

Inspire Investing’s Tandem Diabetes Care TNDM Stock Holding History

Inspire Investing’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665K Buy
44,097
+17,087
+63% +$298K 0.03% 898
2026
Q1 		$518K Buy
27,010
+5,944
+28% +$129K 0.03% 570
2025
Q4 		$463K Sell
21,066
-17,353
-45% -$313K 0.04% 722
2025
Q3 		$466K Buy
38,419
+17,576
+84% +$238K 0.05% 324
2025
Q2 		$389K Buy
20,843
+2,950
+16% +$58.4K 0.04% 612
2025
Q1 		$343K Buy
+17,893
New +$524K 0.04% 622

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Inspire Investing's TNDM Position: Q2 2026 in Review

Inspire Investing increased its Tandem Diabetes Care (TNDM) stake by 63% in Q2 2026, buying an estimated $298K and bringing the position to 44,097 shares worth $665K. The position accounts for 0.03% of the portfolio, ranked #898.

Inspire Investing first reported a position in TNDM in Q1 2025 and has held it in 6 quarters since. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Inspire Investing held 44,097 shares of Tandem Diabetes Care worth $665K as of Q2 2026.
  • Inspire Investing bought 17,087 Tandem Diabetes Care shares in Q2 2026, an estimated $298K.
  • Tandem Diabetes Care made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #898 holding.
  • Inspire Investing first reported a position in Tandem Diabetes Care in Q1 2025 and has held it in 6 quarters since.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.